Type Beta Transforming Growth Factor is an Inhibitor of Myogenic Differentiation
Overview
Authors
Affiliations
We have investigated the effect of type beta transforming growth factor (TGF-beta) on the differentiation of skeletal muscle myoblasts. TGF-beta potently (ID50 approximately 10 pM) prevents established cell lines and primary cultures of rat and chicken embryo myoblasts from fusing into multinucleated myotubes. Inhibition of morphological differentiation by TGF-beta correlates with inhibition of the expression of muscle-specific mRNAs and proteins, strong induction of extracellular matrix type I collagen and fibronectin, and a marked tendency of the treated myoblasts to aggregate into densely multilayered arrays or clusters. Myogenic differentiation can resume after removal of TGF-beta from the medium. Examination of the time of action of TGF-beta shows that myoblasts stochastically reach a point beyond which they become insensitive to the inhibitory action of TGF-beta. This resistance of committed myoblasts to the inhibitory action of TGF-beta is not associated with any measurable change in the number or affinity of TGF-beta receptors in those cells. The results indicate that TGF-beta is a potent inhibitor of myogenesis and may regulate muscle development in vivo.
Putker K, Schneider A, van de Vijver D, Hildyard J, Aartsma-Rus A, van Putten M PLoS One. 2025; 20(2):e0318944.
PMID: 39999085 PMC: 11856590. DOI: 10.1371/journal.pone.0318944.
TGF-β effects on adipogenesis of 3T3-L1 cells differ in 2D and 3D cell culture conditions.
Umetsu A, Watanabe M, Sato T, Higashide M, Nishikiori N, Furuhashi M FEBS Open Bio. 2024; 14(12):2026-2037.
PMID: 39380256 PMC: 11609592. DOI: 10.1002/2211-5463.13890.
Delaney R, OHalloran K Exp Physiol. 2024; 109(9):1426-1445.
PMID: 39023735 PMC: 11363095. DOI: 10.1113/EP091967.
TGF-β signaling in health, disease, and therapeutics.
Deng Z, Fan T, Xiao C, Tian H, Zheng Y, Li C Signal Transduct Target Ther. 2024; 9(1):61.
PMID: 38514615 PMC: 10958066. DOI: 10.1038/s41392-024-01764-w.
Serum-Circulating microRNAs in Sporadic Inclusion Body Myositis.
Lucchini M, De Arcangelis V, Santoro M, Morosetti R, Broccolini A, Mirabella M Int J Mol Sci. 2023; 24(13).
PMID: 37446317 PMC: 10342054. DOI: 10.3390/ijms241311139.